EY

National Vision Holdings, Inc.

EYEConsumer CyclicalNASDAQ

Specialty Retail

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.99B
+9.0% YoY
Net Income
$29.6M
+203.9% YoY
EBITDA
$158.7M
+77.2% YoY
Free Cash Flow
$48.7M

Scan Results

Daily timeframe
1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 RSI OversoldRSI 29.8, below 30, stock may be oversold
Sep 2 RSI OversoldRSI 25.9, below 30, stock may be oversold
About National Vision Holdings, Inc.

Headquartered within the consumer cyclical sector, National Vision Holdings, Inc. focuses on Specialty Retail services and products. National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. Valued at $1.32B, EYE is a small-cap name in its sector. The company offers eyeglasses and contact lenses, and optical accessory products; and provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, Vista Optical military, and DiscountContacts.com.

Where EYE stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, EYE finished 24.27% below its 150-day moving average ($22.21) and 28.46% below its 200-day moving average ($23.51). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is EYE overbought or oversold?

At the September 3, 2026 close, EYE's RSI(14) was 29.8, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.32B
P/E (TTM)27.00
Fwd P/E13.87
EPS$0.62
Beta0.98
52W Change-26.5%
ROE5.8%
Analysis

The company holds $36.4M in cash, though total debt stands at $697.0M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $48.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 5.8% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.64B (2022) to $1.99B (2025), reflecting a 21% increase over the period.

Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. No single metric tells the full story. Reviewing EYE's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Consumer Cyclical stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms